Neuro Kinetics, Inc. (NKI) www.neuro-kinetics.com located in Pennsylvania has developed a device called the “I-Portal Portable Assessment System” (I-PAS) designed to diagnose concussions at the early stage by accurately using a virtual-reality headset to assess brain injuries. I-PAS has received financial support from both the Department of Defense (DOD) and the National Football League and is currently testing the device at a number of military facilities.
The company recently announced that NKI is one of only a few vendors chosen to sign a Cooperative Research and Development Agreement (CRADA) with the Walter Reed National Military Medical Center (WRNMMC).
With this agreement, I-PAS will be used to evaluate persons with a history of Traumatic Brain Injury (TBI). Clinicians and researchers at WRNMMC are interested in finding the right solutions to accurately diagnose and monitor Traumatic Brain Injuries (TBI).
The study will be conducted as a non-randomized trial to compare a group of individuals without a history of TBI to another group of participants who have a confirmed history of TBI. Subjects will be tested using several devices including NKI’s I-PAS.
Also, last spring NKI announced that a patent had been issued to use the I-Portal technology to accurately measure the various dynamics of eye reflexes. The eye tracking assessment and technology addresses separate stimulation of one pupil while accurately measuring both the stimulated pupil and the unstimulated pupil.
“This is an exciting time at NKI”, reports CTO and Co-Inventor, Alex Kiderman. “We are preparing to launch several new technologies and begin a large and pivotal clinical study to prove the diagnostic effectiveness of NKI’s easy to interpret “Concussion Score ™” if cleared by FDA. The score is a derivative of neuro-biomarkers gathered using I-Portal technology and is expected to be the FDA’s first concussion clearance.